NCT04971226 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 101
- group Id
- BG001
- value
- 100
- group Id
- BG002
- value
- 102
- group Id
- BG003
- value
- 102
- group Id
- BG004
- value
- 405
- units
- Participants
- groups
- description
- Patients took asciminib 80 mg QD under fasting conditions on ongoing basis.
- id
- BG000
- title
- Asciminib (Imatinib Stratum)
- description
- Patients took ascimimib 80 mg QD under fasting conditions on ongoing basis.
- id
- BG001
- title
- Asciminib (2nd Generation TKI Stratum)
- description
- Patients took on ongoing basis the Investigator selected TKI (imatinib)
- id
- BG002
- title
- Investigator Selected TKI (Imatinib Stratum)
- description
- Patients took on ongoing basis the 2G investigator selected TKIs (nilotinib, or dasatinib, or bosutinib)
- id
- BG003
- title
- Investigator Selected TKI (2nd Generation TKI Stratum)
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 70
- group Id
- BG003
- value
- 85
- group Id
- BG004
- value
- 310
- title
- 18 to <65 years
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 70
- title
- 65 to <75 years
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 25
- title
- >= 75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 37
- group Id
- BG003
- value
- 42
- group Id
- BG004
- value
- 149
- title
- Female
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 65
- group Id
- BG003
- value
- 60
- group Id
- BG004
- value
- 256
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 63
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 66
- group Id
- BG003
- value
- 44
- group Id
- BG004
- value
- 218
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 4
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 34
- group Id
- BG003
- value
- 56
- group Id
- BG004
- value
- 180
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 60
- group Id
- BG002
- value
- 64
- group Id
- BG003
- value
- 61
- group Id
- BG004
- value
- 247
- title
- Low
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 27
- group Id
- BG004
- value
- 113
- title
- Intermediate
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 45
- title
- High
- description
- ELTS score is a predictive and prognostic score used to estimate the risk of progression and survival risk in newly diagnosed patients with CML-CP.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- EUTOS Long-Term Survival (ELTS) score
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 101
- group Id
- BG001
- value
- 100
- group Id
- BG002
- value
- 102
- group Id
- BG003
- value
- 102
- group Id
- BG004
- value
- 405
- units
- Participants
- groups
- description
- Patients took asciminib 80 mg QD under fasting conditions on ongoing basis.
- id
- BG000
- title
- Asciminib (Imatinib Stratum)
- description
- Patients took ascimimib 80 mg QD under fasting conditions on ongoing basis.
- id
- BG001
- title
- Asciminib (2nd Generation TKI Stratum)
- description
- Patients took on ongoing basis the Investigator selected TKI (imatinib)
- id
- BG002
- title
- Investigator Selected TKI (Imatinib Stratum)
- description
- Patients took on ongoing basis the 2G investigator selected TKIs (nilotinib, or dasatinib, or bosutinib)
- id
- BG003
- title
- Investigator Selected TKI (2nd Generation TKI Stratum)
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 70
- group Id
- BG003
- value
- 85
- group Id
- BG004
- value
- 310
- title
- 18 to <65 years
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 22
- group Id
- BG003
- value
- 12
- group Id
- BG004
- value
- 70
- title
- 65 to <75 years
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 25
- title
- >= 75 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 39
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 37
- group Id
- BG003
- value
- 42
- group Id
- BG004
- value
- 149
- title
- Female
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 65
- group Id
- BG003
- value
- 60
- group Id
- BG004
- value
- 256
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 63
- group Id
- BG001
- value
- 45
- group Id
- BG002
- value
- 66
- group Id
- BG003
- value
- 44
- group Id
- BG004
- value
- 218
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 4
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 53
- group Id
- BG002
- value
- 34
- group Id
- BG003
- value
- 56
- group Id
- BG004
- value
- 180
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 60
- group Id
- BG002
- value
- 64
- group Id
- BG003
- value
- 61
- group Id
- BG004
- value
- 247
- title
- Low
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 30
- group Id
- BG003
- value
- 27
- group Id
- BG004
- value
- 113
- title
- Intermediate
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 8
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 45
- title
- High
- description
- ELTS score is a predictive and prognostic score used to estimate the risk of progression and survival risk in newly diagnosed patients with CML-CP.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- EUTOS Long-Term Survival (ELTS) score
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle